Literature DB >> 20413034

Improved quantity and quality of life: a winning combination to treat advanced heart failure.

Randall C Starling.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20413034     DOI： 10.1016/j.jacc.2010.03.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

Review 1.  Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Abigale L Ottenberg; Monica R Freeman; Paul S Mueller
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 2.  Adult heart transplant: indications and outcomes.

Authors:  M Chadi Alraies; Peter Eckman
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

3.  Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?

Authors:  James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne Stevenson; Marissa Miller; James B Young
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-15       Impact factor: 5.209

4.  Quality of life among patients with left ventricular assist device: Comparison of two populations.

Authors:  Zeliha Özdemir Köken; Ümit Kervan; Murat Avşar; Sinan Sabit Kocabeyoğlu; Mustafa Paç
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

5.  Initial 3-year outcomes with left ventricular assist devices in a country with a nascent heart transplantation program.

Authors:  Yuriy Pya; Makhabbat Bekbossynova; Saltanat Jetybayeva; Serik Bekbossynov; Saltanat Andossova; Roman Salov; Assel Medressova; Svetlana Novikova; Muradym Murzagaliyev
Journal:  ESC Heart Fail       Date:  2015-10-30

6.  Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis.

Authors:  Iosif Taleb; James Wever-Pinzon; Wenyan Wang; Antigone Koliopoulou; Elizabeth Dranow; Tao Yu; Lixue Yin; Stephen H McKellar; Josef Stehlik; James C Fang; Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos
Journal:  Heart Lung Circ       Date:  2019-12-13       Impact factor: 2.975

7.  The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure.

Authors:  Juan F Delgado; Fabrizio Oliva; Alexander Reinecke
Journal:  Eur Heart J Suppl       Date:  2017-03-08       Impact factor: 1.803
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.